Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net income	$ 245,838	$ 217,710
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	87,369	72,296
Share-based compensation	7,171	6,235
Excess tax benefits from share-based compensation	(714)	(1,764)
Changes in operating assets and liabilities	59,144	6,465
Net cash provided by operating activities	398,808	300,942
Investing activities:
Purchases of property, plant and equipment	(78,045)	(48,391)
Proceeds from sale of property, plant and equipment	5,895	16,863
Proceeds from divestitures of businesses	25,939	10,345
Acquisitions of businesses and other investing activities	(1,374,734)	(19,489)
Net cash used in investing activities	(1,420,945)	(40,672)
Financing activities:
Proceeds from debt	2,890,000	31,599
Payments on debt	(1,784,585)	(26,767)
Share-based awards exercised	(1,063)	(5,429)
Dividends paid	(115,876)	(114,043)
Purchases of stock	(72,919)	0
Other financing activities	(1,593)	(1,354)
Net cash provided by (used in) financing activities	913,964	(115,994)
Effect of exchange rate changes on cash and cash equivalents	4,248	(16,454)
Net (decrease) increase in cash and cash equivalents	(103,925)	127,822
Cash and cash equivalents at beginning of period	714,701	990,166
Cash and cash equivalents at end of period	$ 610,776	$ 1,117,988